News

Lindsay Australia (ASX:LAU) Posts Nearly 19% Revenue Growth Despite Profit Decline in FY24

Lindsay Australia Limited (ASX:LAU)is an ASX-listed company that is engaged in integrated transport, logistics, and rural supply services. For the financial year ending 30 June 2024 (FY24), LAU achieved revenue growth of 18.9% YoY to AUD 804.37 million, driven by higher sales in freight …

Team Kalkine | 20 January 2025

Neuren Pharmaceuticals (ASX:NEU) Expects DAYBUE™ Revenue Growth with Boost in Future Royalties Potential

Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian company that focuses on developing innovative drug therapies for neurological disorders. The company’s product, DAYBUE™ (trofinetide), has received approval from the US FDA.

Team Kalkine | 15 January 2025

Stanmore Resources (ASX:SMR) Secures Key Contracts and Expands Project Portfolio in Q3FY24

Stanmore Resources Ltd (ASX:SMR)is an ASX-listed mining company that produces and sells metallurgical coal, a critical raw material for steelmaking.

Team Kalkine | 14 January 2025

Treasury Wine (ASX:TWE) projects optimistic FY25 targets, strengthens global presence with strategic acquisitions

ASX-listed Treasury Wine Estates Limited (ASX:TWE)manages wine business through three key activities, wine production, grape growing and sourcing and wine marketing, sales and distribution. Recently, the company has expanded its portfolio through acquisition of DAOU – a luxury wine brand. Business integration is in …

Team Kalkine | 13 January 2025

Betashares Crude Oil Index Currency Hedged Complex ETF (ASX: OOO) Provides 12% Annual Return Amid Oil Price Movements

The Betashares Crude Oil Index Currency Hedged Complex ETF (ASX: OOO) is an exchange-traded fund designed to provide exposure to crude oil futures, specifically tracking the performance of West Texas Intermediate (WTI) crude oil. This exchange-traded fund offers a unique combination of oil price …

Team Kalkine | 10 January 2025

Clinuvel Pharmaceuticals (ASX:CUV) Celebrates 8th Consecutive Year of  Profit Growth in FY24

Headquartered in Melbourne, Clinuvel Pharmaceuticals Limited (ASX:CUV) is an international specialty pharmaceutical company. The company is focused on developing and commercialising therapies for patients with genetic, metabolic, systemic, and life-threatening acute conditions. CUV’s flagship product is SCENESSE® (afamelanotide 16mg). Notably, the company has demonstrated …

Team Kalkine | 08 January 2025

ASX 200 jumps 0.77% as decline in core inflations sparks rate cut hopes

Index Update: The S&P/ASX 200 closed higher on Wednesday, gaining 64.00 points 0.77% to close at 8,349.10 as a decline in monthly core monthly inflation boosted expectations that the Reserve Bank of Australia could cut interest rates as soon as next month. Notably, the …

Team Kalkine | 08 January 2025

PlaySide Studios (ASX:PLY) Projects Slight Drop in FY25 Revenue and EBITDA

PlaySide Studios Limited (ASX:PLY) is an ASX-listed video game developer and publisher with a diverse portfolio of approximately 60 titles. The company creates games across multiple platforms, including mobile, PC/console, virtual reality, and mixed reality.

Team Kalkine | 07 January 2025

Nido Education (ASX:NDO) targets AUD 161Mn in revenue and AUD 20 in NPAT in FY24

Nido Education Limited (ASX:NDO) is anASX listed company that owns, operates and manages long-term early childhood education and care services. The services are offered to children from six weeks old up to school age. In the first half of the financial year 2024 (1HFY24), …

Team Kalkine | 06 January 2025

Lovisa Holdings (ASX:LOV) Expands Global Footprint: 27 New Stores Opened in FY25 So Far

Lovisa Holdings Limited (ASX:LOV) is an Australian-based global fashion jewellery retailer specialising in affordable, trend-driven accessories. For the 12 months ending 30 June 2024 (FY24), Lovisa delivered revenue of AUD 698.7 million, a 17.1% increase from FY23. The revenue growth was primarily attributed to …

Team Kalkine | 02 January 2025